Cofoe Medical Technology Co.,Ltd. (SHE:301087)

Cofoe Medical Technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	2,830	2,706	2,869	2,129	2,324	1,456
Other Revenue	148.02	148.02	108.05	146.74	51.66	5.79
Revenue	2,978	2,854	2,977	2,276	2,375	1,462
Revenue Growth (YoY)	-7.59%	-4.14%	30.82%	-4.19%	62.46%	34.49%
Cost of Revenue	1,603	1,670	1,839	1,296	1,376	906.23
Gross Profit	1,376	1,184	1,137	979.57	999.13	555.8
Selling, General & Admin	1,042	851.63	740.79	471.08	483.56	407.42
Research & Development	104.49	114.33	118.42	70.59	43.11	15.74
Other Operating Expenses	-0.9	8.18	12.65	6.24	-0.36	1
Operating Expenses	1,153	973.55	886.23	558.69	529.48	427.29
Operating Income	222.34	210.31	251.23	420.89	469.65	128.51
Interest Expense	-19.74	-13.5	-10.85	-6.81	-1.44	-5.1
Interest & Investment Income	104.61	82.02	102.64	14.41	8.3	1.58
Earnings From Equity Investments	-	-	-	-	-1.43	-
Currency Exchange Gain (Loss)	0.16	0.16	0.36	-0.19	-0.1	-0.01
Other Non Operating Income (Expenses)	3.81	-3.27	-2.49	-0.44	-2.06	-0.68
EBT Excluding Unusual Items	311.18	275.71	340.89	427.86	472.91	124.3
Impairment of Goodwill	-	-	-0.15	-	-	-
Gain (Loss) on Sale of Investments	-32.44	-1.56	4.4	6.02	-	-
Gain (Loss) on Sale of Assets	-0.35	4.59	6.47	0.14	0.22	0.02
Asset Writedown	16.76	-2.24	-35.14	-0.05	-0.01	-0
Legal Settlements	-2.52	-2.52	-	-0.16	-	-
Other Unusual Items	11.72	11.72	17.91	74.51	26.9	21.64
Pretax Income	304.36	285.71	334.39	508.33	500.02	145.96
Income Tax Expense	41.93	32.84	32.37	78.74	75.48	21.76
Earnings From Continuing Operations	262.43	252.87	302.02	429.59	424.54	124.2
Minority Interest in Earnings	1.81	1.41	-0.34	-0.73	-0.59	-0.52
Net Income	264.24	254.28	301.68	428.86	423.95	123.69
Net Income to Common	264.24	254.28	301.68	428.86	423.95	123.69
Net Income Growth	-29.75%	-15.71%	-29.65%	1.16%	242.76%	86.76%
Shares Outstanding (Basic)	201	205	208	165	156	156
Shares Outstanding (Diluted)	202	205	208	165	156	156
Shares Change (YoY)	-2.79%	-1.70%	26.56%	5.47%	0.08%	41.17%
EPS (Basic)	1.32	1.24	1.45	2.60	2.72	0.79
EPS (Diluted)	1.31	1.24	1.45	2.60	2.72	0.79
EPS Growth	-27.90%	-14.48%	-44.23%	-4.25%	242.51%	32.29%
Free Cash Flow	242	20.6	-540.87	-273.25	122.2	-48.02
Free Cash Flow Per Share	1.20	0.10	-2.60	-1.66	0.78	-0.31
Dividend Per Share	1.800	1.200	1.200	1.231	-	0.154
Dividend Growth	50.00%	-	-2.50%	-	-	-
Gross Margin	46.19%	41.48%	38.21%	43.05%	42.06%	38.02%
Operating Margin	7.46%	7.37%	8.44%	18.50%	19.77%	8.79%
Profit Margin	8.87%	8.91%	10.13%	18.85%	17.85%	8.46%
Free Cash Flow Margin	8.13%	0.72%	-18.17%	-12.01%	5.15%	-3.28%
EBITDA	336.62	293.23	292.34	449.78	486.09	135.09
EBITDA Margin	11.30%	10.27%	9.82%	19.77%	20.46%	9.24%
D&A For EBITDA	114.28	82.92	41.11	28.89	16.44	6.58
EBIT	222.34	210.31	251.23	420.89	469.65	128.51
EBIT Margin	7.46%	7.37%	8.44%	18.50%	19.77%	8.79%
Effective Tax Rate	13.78%	11.49%	9.68%	15.49%	15.10%	14.91%
Revenue as Reported	2,978	2,854	2,977	2,276	2,375	1,462
Advertising Expenses	-	206.59	151.96	86.71	97.51	51.78

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.